Pheast Therapeutics
1 known investors
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute. The company focuses on translating scientific discoveries into clinical therapies for patients.
BiotechHealthtechMedical Devices
Founders & leadership
IW
Irv WeissmanCofounder, Scientific Advisor, Board Director
RM
Ravi MajetiCofounder, Scientific Advisor, Board Observer
AB
Amira BarkalPrincipal Founder, Scientific Advisor, Board Director
RM
Roy MauteCofounder & Chief Executive Officer
Investors · 1
In the news
- Pheast Therapeutics Raises $76M in Series A Fundingfinsmes.com · 2022
- Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancerprnewswire.com · 2022